We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
-6.56%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$855M
AUM Growth
+$250M
Cap. Flow
+$327M
Cap. Flow %
38.29%
Top 10 Hldgs %
13.1%
Holding
788
New
316
Increased
155
Reduced
106
Closed
211

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$13.6M
2
MRK icon
Merck
MRK
+$12.5M
3
ISRG icon
Intuitive Surgical
ISRG
+$11.1M
4
DOCU
DocuSign
DOCU
+$10.9M
5
PODD icon
Insulet
PODD
+$10.8M

Top Sells

Rank Stock Value
1
NDAQ icon
Nasdaq
NDAQ
+$7.26M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$6.86M
3
INCY icon
Incyte
INCY
+$6.31M
4
FIS icon
Fidelity National Information Services
FIS
+$5.73M
5
ABBV icon
AbbVie
ABBV
+$4.95M

Sector Composition

Rank Sector Weight
1 Technology 20.41%
2 Consumer Discretionary 17.68%
3 Healthcare 16.13%
4 Industrials 12.13%
5 Financials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRB icon
76
H&R Block
HRB
$5.58B
$2.65M 0.31%
+61,506
New +$2.27M
TROW icon
77
T. Rowe Price
TROW
$23.9B
$2.64M 0.31%
+25,163
New +$2.83M
SE icon
78
Sea Limited
SE
$65.4B
$2.64M 0.31%
60,012
+31,486
+110% +$1.54M
XEL icon
79
Xcel Energy
XEL
$48.8B
$2.63M 0.31%
45,918
+41,462
+930% +$2.49M
BBBY
80
Bed Bath & Beyond
BBBY
$481M
$2.62M 0.31%
182,042
+84,165
+86% +$2.06M
GH icon
81
Guardant Health
GH
$21.7B
$2.54M 0.3%
85,809
+6,193
+8% +$218K
TSM icon
82
TSMC
TSM
$2.1T
$2.54M 0.3%
+29,200
New +$2.76M
AI icon
83
C3.ai
AI
$1.43B
$2.53M 0.3%
+99,026
New +$3.31M
FND icon
84
Floor & Decor
FND
$6.13B
$2.51M 0.29%
27,747
+22,937
+477% +$2.34M
KMB icon
85
Kimberly-Clark
KMB
$36.3B
$2.5M 0.29%
+20,719
New +$2.68M
PENN icon
86
PENN Entertainment
PENN
$2.75B
$2.5M 0.29%
109,082
+42,136
+63% +$1.02M
TS icon
87
Tenaris
TS
$28.9B
$2.49M 0.29%
78,679
-257
-0.3% -$8.3K
RCL icon
88
Royal Caribbean
RCL
$85.1B
$2.49M 0.29%
+26,972
New +$2.7M
TNET icon
89
TriNet
TNET
$3.02B
$2.41M 0.28%
+20,679
New +$2.18M
NOW icon
90
ServiceNow
NOW
$115B
$2.39M 0.28%
21,395
-16,780
-44% -$1.91M
C icon
91
Citigroup
C
$222B
$2.35M 0.27%
57,120
+38,488
+207% +$1.69M
WBA
92
DELISTED
Walgreens Boots Alliance
WBA
$2.33M 0.27%
+104,804
New +$2.79M
DK icon
93
Delek US
DK
$4.16B
$2.33M 0.27%
81,852
+52,839
+182% +$1.43M
SHEL icon
94
Shell
SHEL
$254B
$2.31M 0.27%
+35,831
New +$2.23M
PARA
95
DELISTED
Paramount Global Class B
PARA
$2.28M 0.27%
176,500
+75,719
+75% +$1.12M
ENVX icon
96
Enovix
ENVX
$892M
$2.26M 0.26%
205,984
-97,886
-32% -$1.4M
DXCM icon
97
DexCom
DXCM
$31.5B
$2.25M 0.26%
24,134
+1,150
+5% +$130K
LAZR
98
DELISTED
Luminar Technologies
LAZR
$2.24M 0.26%
32,765
+10,476
+47% +$961K
USB icon
99
US Bancorp
USB
$98.2B
$2.22M 0.26%
67,286
+59,127
+725% +$2.15M
NVCR icon
100
NovoCure
NVCR
$1.73B
$2.22M 0.26%
137,721
+71,989
+110% +$2.08M
2 3
4
5 6

Similar funds

PP
Pegasus Partners Mequon, Wisconsin $1.07B AUM 32.32% 1-Year Est. Return
ECM
Ensemble Capital Management San Francisco, California $1.18B AUM 41.81% 1-Year Est. Return
GCAC
Guardian Capital Advisors (Canada) Toronto, Ontario, Canada $1.02B AUM 25.29% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return
D
Diversified Wilmington, Delaware $911M AUM 31% 1-Year Est. Return
GFS
GYL Financial Synergies West Hartford, Connecticut $1.33B AUM 34.46% 1-Year Est. Return
FTIS
First Trust Investment Solutions Naples, Florida $888M AUM 34.3% 1-Year Est. Return
AIA
Alera Investment Advisors Deerfield, Illinois $851M AUM 29.76% 1-Year Est. Return

Seven Eight Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Seven Eight Capital held 788 positions worth $855M, up 41% from $605M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Seven Eight Capital deployed $327M of net new capital in Q3 2023, opening 316 new positions and adding to 155 existing holdings. Its largest new stake was Merck: 115,677 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $6.86M trimmed.

  • Seven Eight Capital's largest Q3 2023 buy was Merck: 115,677 shares worth $11.9M.
  • Seven Eight Capital added most to Edwards Lifesciences in Q3 2023, an estimated $13.6M increase.
  • Seven Eight Capital's biggest Q3 2023 reduction was BioMarin Pharmaceuticals, cutting an estimated $6.86M.
  • Seven Eight Capital fully exited Nasdaq in Q3 2023, selling an estimated $7.26M.
  • Seven Eight Capital's ten largest holdings make up 13% of its $855M portfolio in Q3 2023.
  • Seven Eight Capital opened 316 new positions and closed 211 in Q3 2023.
  • Seven Eight Capital's portfolio value rose 41% quarter-over-quarter to $855M.

Based on Seven Eight Capital's 13F filing for Q3 2023, filed 14 Nov 2023.